A healthcare professional holds a Theranova dialyzer by a AK 98 machine

A New Class of Dialyser Membrane Technology

With the Theranova dialyser, Vantive has established a whole new class of dialyser technology with the MCO membrane that enables HDx therapy.1

Haemodialysis one step closer to the natural kidney

HDx therapy, uniquely enabled by the first-of-its-kind Theranova dialyser, provides expanded haemodialysis therapy, thanks to the technology of its MCO membrane, bringing haemodialysis filtration one step closer to the natural kidney2 by removing large-middle molecule uraemic toxins linked to cardiovascular disease, inflammation and other dialysis-related comorbidities.3

Female patient receiving HDx therapy in a hospital

Therapy with no special requirements

By simply changing the traditional (high-flux) dialyser to the Theranova dialyser with the MCO membrane, diffusion and convection are conveniently combined inside the hollow fibre dialyser to perform HDx therapy, with no special requirement of a particular hardware, preparation of replacement fluid, or additional nursing skill, beyond what is necessary to perform traditional haemodialysis in standard mode.4 

Medical professional providing HDx therapy to a woman in a hospital setting

More about the Theranova dialyser

Discover more about how the Theranova dialyser works, the evidence that supports its use and available resources for additional information. 

Learn more
An HD patient undergoing hemodialysis with the AK 98 dialysis system and Revaclear dialyzer
Learn more
Healthcare professional sitting at table on laptop

Renal care resources to support clinicians

We offer numerous resources that provide detailed information on using our AK 98 dialysis system, which can deliver HDx therapy using the Theranova dialyser, and on our support services for both clinicians and patients.

View resources

Contact us

Connect with Vantive to learn more

Get in touch

Vantive, AK 98, HDx, MCO and Theranova are trademarks of Vantive Health LLC or its affiliates.

References

  1. Device Classification Under Section 513(f)(2)(DeNovo). Accessdata.fda.gov. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN190042. Published 2020.

  2. Zweigart C, Boschetti-de-Fierro A, Hulko M, et al. Medium cut-off membranes — closer to the natural kidney removal function. Int J Artif Organs. 2017;40(7):328-334.

  3. Ronco C, La Manna G. Expanded hemodialysis: a new therapy for a new class of membranes. Contrib Nephrol. 2017;190:124-133.

  4. Ronco C. The rise of expanded hemodialysis. Blood Purif. 2017;44(2):I-VIII.